Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Capital First gains on raising funds through issue of NCDs

24-Nov2017

Capital First gains on raising funds through issue of NCDs

Capital First is currently trading at Rs. 706.90, up by 5.80 points or 0.83% from its previous closing of Rs. 701.10 on the BSE.

The scrip opened at Rs. 695.00 and has touched a high and low of Rs. 710.50 and Rs. 695.00 respectively. So far 12,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 839.00 on 13-Sep-2017 and a 52 week low of Rs. 510.75 on 22-Dec-2016.

Last one week high and low of the scrip stood at Rs. 716.85 and Rs. 688.00 respectively. The current market cap of the company is Rs. 6,985.00 crore.

The promoters holding in the company stood at 35.97%, while Institutions and Non-Institutions held 37.45% and 26.59% respectively.

Capital First (CFL) has raised Rs 52.53 crore by issue of Non-Convertible Debentures (NCDs) on private placement basis. The company has also received an approval for allotment of 500 NCDs having Face Value of Rs 10 lakh each. The said NCDs shall be listed on National Stock Exchange of India. The Debenture Committee constituted by the board of directors of the company at its meeting held on November 23, 2017, approved for the same.

Capital First (CFL) is an MSME and consumer financing company which provides debt financing to these segments and also offers home loans, two wheeler loans and durable loans to entry and mid-level salaried employees of corporates.



Related News

View all news

IndusInd Bank surges on reporting 5% rise in Q2 net profit

IndusInd Bank is currently trading at Rs. 1663.60, up by 36.75 points or 2.26% from its previous closing of Rs. 1626.85 on the BSE.The scrip opened at Rs. 1638.00 and has touched a high and low of Rs.......

Lupin rises with arm partnering with ASHA, NPWH

Lupin is currently trading at Rs. 897.00, up by 16.55 points or 1.88% from its previous closing of Rs. 880.45 on the BSE.The scrip opened at Rs. 889.80 and has touched a high and low of Rs. 910.00 and......

Alembic Pharma surges with receiving USFDA's tentative approval for Alogliptin Tablet

Alembic Pharmaceuticals is currently trading at Rs. 602.35, up by 6.50 points or 1.09% from its previous closing of Rs. 595.85 on the BSE.The scrip opened at Rs. 596.65 and has touched a high and low of......

Top News

View all news

Shalimar Paints lays down foundation of Nashik manufacturing plant

Shalimar Paints has laid down the foundation of a manufacturing unit to be rebuilt in Nashik, in the state of Maharashtra. The company set to commence operations by April 2019 with a planned production......

Delta Corp reports 11% rise in Q2 consolidated net profit

Delta Corp has reported results for second quarter ended September 30, 2018.The company has reported over 2-fold jump in its net profit at Rs 63.51 crore for the quarter under review as compared to Rs......

PNB plans to sell non-core assets worth Rs 8,600 crore during FY19

Punjab National Bank (PNB) has recognized various assets, including its housing finance arm, for sale and hopes to realise Rs 8,600 crore from these non-core assets during the current fiscal. Meanwhile,......